Influenza Vaccine Market for West Europe
Influenza vaccine market for West Europe was more than US$ 500 Million. United Kingdom is having the highest seasonal influenza vaccine market share followed by Germany and France respectively. In children vaccination, United Kingdom is the leader and France holds the second spot. In adult vaccination United Kingdom and Germany have a close fight for top slot. Download full Report: http://www.renub.com/influenza-vaccine-market-and-forecast-in-west-europe-netherlands-germany-france-ireland-luxembourg-poland-and-united-kingdom-by-child-and-adult-1061-p.php
Influenza vaccine market for West Europe was more than US$ 500 Million. United Kingdom is having the highest seasonal influenza vaccine market share followed by Germany and France respectively. In children vaccination, United Kingdom is the leader and France holds the second spot. In adult vaccination United Kingdom and Germany have a close fight for top slot.
Download full Report: http://www.renub.com/influenza-vaccine-market-and-forecast-in-west-europe-netherlands-germany-france-ireland-luxembourg-poland-and-united-kingdom-by-child-and-adult-1061-p.php
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
<strong>Influenza</strong> <strong>Vaccine</strong> <strong>Market</strong> & Forecast in (<strong>West</strong> <strong>Europe</strong>) Netherlands, Germany, France, Ireland,<br />
Luxembourg, Poland and United Kingdom By (Child & Adult)<br />
<strong>Influenza</strong> <strong>Vaccine</strong> <strong>Market</strong> <strong>for</strong> <strong>West</strong> <strong>Europe</strong><br />
Analyst View:<br />
<strong>Influenza</strong> vaccine market <strong>for</strong> <strong>West</strong> <strong>Europe</strong> was more than US$ 500 Million. United Kingdom is<br />
having the highest seasonal influenza vaccine market share followed by Germany and France<br />
respectively.<br />
Report Title:<br />
<strong>Influenza</strong> <strong>Vaccine</strong> <strong>Market</strong> & Forecast in (<strong>West</strong> <strong>Europe</strong>) Netherlands, Germany, France,<br />
Ireland, Luxembourg, Poland and United Kingdom By (Child & Adult)<br />
Download full Report:<br />
http://www.renub.com/influenza-vaccine-market-and-<strong>for</strong>ecast-in-west-europe-netherlands-<br />
germany-france-ireland-luxembourg-poland-and-united-kingdom-by-child-and-adult-1061-<br />
p.php<br />
In children vaccination, United Kingdom is the leader and France holds the second spot. In adult<br />
vaccination United Kingdom and Germany have a close fight <strong>for</strong> top slot.<br />
In total 7 <strong>Europe</strong> Countries influenza vaccine market and its vaccinated population numbers<br />
have been captured in the report. All the 7 <strong>Europe</strong> countries are as follows: Netherlands,<br />
Germany, France, Ireland, Luxembourg, Poland and United Kingdom.<br />
Scope of Study<br />
<br />
<br />
<strong>Influenza</strong> <strong>Vaccine</strong> <strong>Market</strong> & Forecast has been sub divided into two segments Children<br />
<strong>Influenza</strong> <strong>Vaccine</strong> <strong>Market</strong> & Forecast and Adult <strong>Influenza</strong> <strong>Vaccine</strong> <strong>Market</strong> & Forecast.<br />
<strong>Influenza</strong> <strong>Vaccine</strong> <strong>Market</strong> share & Forecast, Children <strong>Influenza</strong> <strong>Vaccine</strong> <strong>Market</strong> share &<br />
Forecast and Adult <strong>Influenza</strong> <strong>Vaccine</strong> <strong>Market</strong> share & Forecast.<br />
© Renub Research LLP Page 1 of 3
Million US$<br />
<strong>Influenza</strong> <strong>Vaccine</strong> <strong>Market</strong> & Forecast in (<strong>West</strong> <strong>Europe</strong>) Netherlands, Germany, France, Ireland,<br />
<br />
Luxembourg, Poland and United Kingdom By (Child & Adult)<br />
<strong>Influenza</strong> Vaccinated Population & Forecast has been sub divided into two segments<br />
Children <strong>Influenza</strong> Vaccinated Population & Forecast and Adult <strong>Influenza</strong> Vaccinated<br />
Population & Forecast.<br />
<strong>Market</strong> Dynamics<br />
1 Seasonal <strong>Influenza</strong> <strong>Vaccine</strong> - Growth Drivers<br />
(a) <strong>Vaccine</strong> Manufacturers Plan to Increase Flu <strong>Vaccine</strong> Production<br />
(b) Growing Child & Ageing Population in <strong>West</strong>ern <strong>Europe</strong>an Region<br />
(c) Rising Healthcare Expenditure Share of the <strong>West</strong>ern <strong>Europe</strong> Countries GDP<br />
2 Seasonal <strong>Influenza</strong> <strong>Vaccine</strong> – Challenges<br />
(a) Regulatory Challenges with New and Novel <strong>Influenza</strong> <strong>Vaccine</strong>s<br />
(b) Lack of Healthcare Infrastructure<br />
(c) Limited Reimbursement and Access to the <strong>Vaccine</strong>s<br />
Countries Studied in the Report are As follows<br />
1. Netherlands<br />
2. Germany<br />
3. France<br />
4. Ireland<br />
5. Luxembourg<br />
6. Poland<br />
7. United Kingdom<br />
<strong>West</strong>ern <strong>Europe</strong> Countries - Seasonal <strong>Influenza</strong> <strong>Vaccine</strong> <strong>Market</strong> (Million US$), 2011 - 2016<br />
2,011 2,012 2,013 2,014 2,015 2,016<br />
Source: Renub Research Analysis<br />
© Renub Research LLP Page 2 of 3
<strong>Influenza</strong> <strong>Vaccine</strong> <strong>Market</strong> & Forecast in (<strong>West</strong> <strong>Europe</strong>) Netherlands, Germany, France, Ireland,<br />
Luxembourg, Poland and United Kingdom By (Child & Adult)<br />
<strong>West</strong>ern <strong>Europe</strong> Countries – Forecast <strong>for</strong> Seasonal <strong>Influenza</strong> <strong>Vaccine</strong> <strong>Market</strong> Share (Percent), 2017 -<br />
2022<br />
Country 2017 2018 2019 2020 2021 2022<br />
Netherlands XXXXX XXXXX XXXXX XXXXX XXXXX XXXXX<br />
Germany XXXXX XXXXX XXXXX XXXXX XXXXX XXXXX<br />
France XXXXX XXXXX XXXXX XXXXX XXXXX XXXXX<br />
Ireland XXXXX XXXXX XXXXX XXXXX XXXXX XXXXX<br />
Luxembourg XXXXX XXXXX XXXXX XXXXX XXXXX XXXXX<br />
Poland XXXXX XXXXX XXXXX XXXXX XXXXX XXXXX<br />
United Kingdom XXXXX XXXXX XXXXX XXXXX XXXXX XXXXX<br />
Source: Renub Research Analysis<br />
<strong>Vaccine</strong>s Report:<br />
http://www.renub.com/vaccines-12-c.php<br />
Renub Research - North America<br />
Rajat Gupta<br />
225 Kristie Ln, Roswell<br />
Georgia 30076, United States<br />
Tel: +1-678-302-0700<br />
Email: info@renub.com<br />
www.renub.com<br />
Renub Research - Asia<br />
Ankit Mishra<br />
C – 86, Sector – 10<br />
Noida 201301, India<br />
Tel: +91-120-421-9822 / 424-9780<br />
Email: info@renub.com<br />
www.renub.com<br />
© Renub Research LLP Page 3 of 3
Change language